Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasonex in Allergic Rhinitis and Intermittent Asthma
NCT00599027Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- May 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of mometasone furoate nasal spray in allergic rhinitis (AR), asthma, sponsored by Organon & Co.. Started May 2008; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on NCT00599027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00599027.